US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neurosense Therapeutics Ltd

0.4267

+0.00631.50%

Post-market: 0.42670.00000.00%16:04 EDT

Volume:167.26K

Turnover:71.93K

Market Cap:16.11M

PE:-0.98

High:0.4500

Open:0.4500

Low:0.4052

Close:0.4204

52wk High:1.98

52wk Low:0.2500

Shares:37.77M

Float Shares:25.85M

Volume Ratio:1.17

T/O Rate:0.65%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4366

EPS(LYR):-0.4366

ROE:-2174.98%

ROA:-247.30%

PB:-10.33

PE(LYR):-0.98

Loading ...

Overview Company News Filings

NeuroSense announces redesigned development plan for PrimeC

NeuroSense Targets Faster, Lower-Cost ALS Approval Path for PrimeC Under Revamped Development Plan

NeuroSense Plans Head-to-Head PrimeC Trial Versus Mitsubishi Tanabe’s Edaravone in ALS

Neurosense Unveils Accelerated, Capital-Efficient Strategy to Advance Primec Toward Potential Approval in ALS

THOMSON REUTERS

NeuroSense Therapeutics Shareholders Authorized Board to Pursue Reverse Stock Split Range 1-for-4 to 1-for-40

NeuroSense Announces Shareholder Letter Availability

NeuroSense Targets December 2026 Canada Filing for PrimeC ALS Drug Amid Phase 3 Paragon Preparations

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)

NeuroSense sees December 2026 as filing date for NDS for PrimeC

NeuroSense Therapeutics Announces Special Shareholder Meeting

NeuroSense Amends JonesTrading Equity Distribution Agreement for up to $3.79 Million Share Sales

Neurosense Therapeutics Ltd Expected to Post Breakeven Results a Share - Earnings Preview

Neurosense Therapeutics - Expects to File Submission to Health Canada in Coming Months

THOMSON REUTERS

Neurosense Therapeutics Announces Press Release Availability

Neurosense Plans Primec New Drug Filing with Health Canada for ALS

Neurosense Therapeutics Ltd. (NRSN) Gets a Buy from Noble Financial

Neurosense Therapeutics Achieves Primary Endpoint in Phase 2B ALS Study

Neurosense Rises as Nerve Disease Drug Shows Promise in Study

NeuroSense says Phase 2b PARADIGM study of PrimeC in ALS met endpoint

Neurosense Says Phase 2b ALS Trial Meets Primary Endpoint, Cuts Tdp-43 vs Placebo (p=0.0421)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/NRSN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRSN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRSN\",,,,,undefined,":{"symbol":"NRSN","market":"US","secType":"STK","nameCN":"Neurosense Therapeutics Ltd","latestPrice":0.4267,"timestamp":1788206400000,"preClose":0.4204,"halted":0,"volume":167262,"hourTrading":{"tag":"盘后","latestPrice":0.4267,"preClose":0.4267,"latestTime":"16:04 EDT","volume":1,"amount":0.4267,"timestamp":1788206643789,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.014985727878211294,"floatShares":25846403,"shares":37766100,"eps":-0.436593,"marketStatus":"Post-Mkt","change":0.0063,"latestTime":"08-31 16:44:03 EDT","open":0.45,"high":0.45,"low":0.4052,"amount":71934,"amplitude":0.106565,"askPrice":0.4565,"askSize":100,"bidPrice":0.4,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.436593,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"listingDate":1639026000000,"exchange":"NASDAQ","adjPreClose":0.4204,"preHourTrading":{"tag":"盘前","latestPrice":0.4565,"preClose":0.4204,"latestTime":"09:27 EDT","volume":4588,"amount":2044.752312,"timestamp":1788182865947,"change":0.0361,"changeRate":0.085871,"amplitude":0.18078},"postHourTrading":{"tag":"盘后","latestPrice":0.4267,"preClose":0.4267,"latestTime":"16:04 EDT","volume":1,"amount":0.4267,"timestamp":1788206643789,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.173332},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRSN\",,,,,undefined,":{"symbol":"NRSN","floatShares":25846403,"roa":"-247.30%","roe":"-2174.98%","lyrEps":-0.436593,"volumeRatio":1.173332,"shares":37766100,"dividePrice":0,"high":0.45,"amplitude":0.106565,"preClose":0.4204,"low":0.4052,"week52Low":0.25,"pbRate":"-10.33","week52High":1.98,"institutionHeld":0,"latestPrice":0.4267,"eps":-0.436593,"divideRate":0,"volume":167262,"delay":0,"ttmEps":-0.436593,"open":0.45,"prevYearClose":0.769,"prevWeekClose":0.4204,"prevMonthClose":0.4652,"prevQuarterClose":0.72,"fiveDayClose":0.375,"twentyDayClose":0.467,"sixtyDayClose":0.7801},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRSN\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"NRSN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774944000000,"name":null,"time":"Pre-MKt","dateTimestamp":1774929600000,"actualEps":null},{"market":"US","date":"2025-08-01","symbol":"NRSN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-04-07","symbol":"NRSN","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2024-12-18","symbol":"NRSN","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1734498000000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-06-24","symbol":"NRSN","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1719201600000,"reportTimeType":"pre","actualEps":-0.35}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRSN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRSN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1773201600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NRSN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NRSN","date":"2026-08-28","current":-0.97734,"percent":0.833191,"low":-12.966568,"twenty":-3.571281,"median":-2.343329,"eighty":-1.558666,"high":-0.395084,"avg":-2.691772,"sd":1.550416,"marketCap":16227478},"quantilePoints":[{"date":"2021-12-10","current":-6.574093,"twenty":-10.190888,"median":-8.533367,"eighty":-7.593999,"marketCap":34566580},{"date":"2021-12-17","current":-6.369292,"twenty":-8.481481,"median":-7.033255,"eighty":-6.696973,"marketCap":33489739},{"date":"2021-12-23","current":-6.010892,"twenty":-7.839759,"median":-6.778893,"eighty":-6.385676,"marketCap":31605268},{"date":"2021-12-31","current":-5.03809,"twenty":-7.126398,"median":-6.420492,"eighty":-5.387602,"marketCap":26490276},{"date":"2022-01-07","current":-5.24289,"twenty":-6.939702,"median":-6.041612,"eighty":-5.268367,"marketCap":27567116},{"date":"2022-01-14","current":-5.632011,"twenty":-6.791181,"median":-5.652491,"eighty":-5.268367,"marketCap":29613113},{"date":"2022-01-21","current":-4.812809,"twenty":-6.737933,"median":-5.611531,"eighty":-5.166254,"marketCap":25305751},{"date":"2022-01-28","current":-3.829767,"twenty":-6.545421,"median":-5.509131,"eighty":-4.931594,"marketCap":20136917},{"date":"2022-02-04","current":-3.725547,"twenty":-6.426636,"median":-5.37601,"eighty":-4.251656,"marketCap":19588925},{"date":"2022-02-11","current":-3.663107,"twenty":-6.40206,"median":-5.24289,"eighty":-3.929516,"marketCap":19260619},{"date":"2022-02-18","current":-3.267658,"twenty":-6.303756,"median":-5.10977,"eighty":-3.725547,"marketCap":17181348},{"date":"2022-02-25","current":-3.14278,"twenty":-6.041612,"median":-5.01761,"eighty":-3.663107,"marketCap":16524736},{"date":"2022-03-04","current":-3.954491,"twenty":-6.010892,"median":-4.91521,"eighty":-3.683921,"marketCap":20792714},{"date":"2022-03-11","current":-2.934649,"twenty":-5.672971,"median":-4.706253,"eighty":-3.645447,"marketCap":15430382},{"date":"2022-03-18","current":-3.246845,"twenty":-5.652491,"median":-4.464649,"eighty":-3.267658,"marketCap":17071913},{"date":"2022-03-25","current":-8.783133,"twenty":-6.369292,"median":-4.706253,"eighty":-3.352784,"marketCap":46181713},{"date":"2022-04-01","current":-7.804917,"twenty":-6.778893,"median":-4.91521,"eighty":-3.579855,"marketCap":41038252},{"date":"2022-04-08","current":-5.89011,"twenty":-7.033255,"median":-5.04833,"eighty":-3.621481,"marketCap":30970201},{"date":"2022-04-14","current":-5.470413,"twenty":-6.846149,"median":-5.01761,"eighty":-3.640654,"marketCap":22105938},{"date":"2022-04-22","current":-6.4995,"twenty":-6.782989,"median":-5.16097,"eighty":-3.659575,"marketCap":26264481},{"date":"2022-04-29","current":-4.54965,"twenty":-6.615053,"median":-5.207035,"eighty":-3.663107,"marketCap":18385137},{"date":"2022-05-06","current":-4.197594,"twenty":-6.514419,"median":-5.05857,"eighty":-3.663107,"marketCap":16962477},{"date":"2022-05-13","current":-3.439319,"twenty":-6.444486,"median":-4.985732,"eighty":-3.653865,"marketCap":13898288},{"date":"2022-05-20","current":-4.073327,"twenty":-6.414348,"median":-4.894729,"eighty":-3.613156,"marketCap":16460316},{"date":"2022-05-27","current":-4.304438,"twenty":-6.377484,"median":-4.641324,"eighty":-3.640654,"marketCap":17394234},{"date":"2022-06-03","current":-3.629217,"twenty":-6.349925,"median":-4.548658,"eighty":-3.579438,"marketCap":16810535},{"date":"2022-06-10","current":-3.679623,"twenty":-6.207023,"median":-4.495488,"eighty":-3.604831,"marketCap":17044015},{"date":"2022-06-17","current":-4.183681,"twenty":-6.073112,"median":-4.437259,"eighty":-3.626123,"marketCap":19378811},{"date":"2022-06-24","current":-4.284493,"twenty":-6.029324,"median":-4.307067,"eighty":-3.635709,"marketCap":19845771},{"date":"2022-07-01","current":-8.316957,"twenty":-6.35638,"median":-4.441325,"eighty":-3.649036,"marketCap":38524143},{"date":"2022-07-08","current":-6.754377,"twenty":-6.429933,"median":-4.495488,"eighty":-3.65473,"marketCap":31286274},{"date":"2022-07-15","current":-5.191797,"twenty":-6.429933,"median":-4.548658,"eighty":-3.657397,"marketCap":24048404},{"date":"2022-07-22","current":-4.61213,"twenty":-6.423442,"median":-4.61213,"eighty":-3.663107,"marketCap":21363388},{"date":"2022-07-29","current":-4.712942,"twenty":-6.40206,"median":-4.762875,"eighty":-3.663107,"marketCap":21830348},{"date":"2022-08-05","current":-4.788551,"twenty":-6.362836,"median":-4.788551,"eighty":-3.66641,"marketCap":22180567},{"date":"2022-08-12","current":-5.368217,"twenty":-6.329755,"median":-4.80068,"eighty":-3.680483,"marketCap":24865583},{"date":"2022-08-19","current":-4.939768,"twenty":-6.265441,"median":-4.838957,"eighty":-3.683921,"marketCap":22881006},{"date":"2022-08-26","current":-5.04058,"twenty":-6.123516,"median":-4.892046,"eighty":-3.688102,"marketCap":23347966},{"date":"2022-09-02","current":-3.184552,"twenty":-6.104613,"median":-4.889362,"eighty":-3.680483,"marketCap":22881006},{"date":"2022-09-09","current":-3.265791,"twenty":-6.041612,"median":-4.838957,"eighty":-3.663107,"marketCap":23464705},{"date":"2022-09-16","current":-3.2008,"twenty":-6.023493,"median":-4.80068,"eighty":-3.629217,"marketCap":22997746},{"date":"2022-09-23","current":-2.599634,"twenty":-6.010892,"median":-4.738145,"eighty":-3.553609,"marketCap":18678372},{"date":"2022-09-30","current":-2.908341,"twenty":-5.930794,"median":-4.697946,"eighty":-3.4664,"marketCap":20896429},{"date":"2022-10-07","current":-2.745864,"twenty":-5.89011,"median":-4.61213,"eighty":-3.363277,"marketCap":19729031},{"date":"2022-10-14","current":-2.778359,"twenty":-5.822469,"median":-4.548658,"eighty":-3.298286,"marketCap":19962510},{"date":"2022-10-21","current":-2.518396,"twenty":-5.795388,"median":-4.495488,"eighty":-3.249543,"marketCap":18094673},{"date":"2022-10-28","current":-2.469653,"twenty":-5.741225,"median":-4.437259,"eighty":-3.184552,"marketCap":17744454},{"date":"2022-11-04","current":-2.420909,"twenty":-5.723606,"median":-4.304438,"eighty":-3.168304,"marketCap":17394234},{"date":"2022-11-11","current":-2.453405,"twenty":-5.672971,"median":-4.278838,"eighty":-3.11156,"marketCap":17627714},{"date":"2022-11-18","current":-3.005177,"twenty":-5.670652,"median":-4.198408,"eighty":-3.038323,"marketCap":21592198},{"date":"2022-11-25","current":-2.84335,"twenty":-5.656123,"median":-4.197594,"eighty":-2.986918,"marketCap":20429470},{"date":"2022-12-02","current":-2.117174,"twenty":-5.636107,"median":-4.157963,"eighty":-2.932864,"marketCap":19670661},{"date":"2022-12-09","current":-1.985243,"twenty":-5.599243,"median":-4.108073,"eighty":-2.912736,"marketCap":18444893},{"date":"2022-12-16","current":-1.758322,"twenty":-5.574667,"median":-4.076348,"eighty":-2.875845,"marketCap":16336571},{"date":"2022-12-23","current":-1.633428,"twenty":-5.521419,"median":-3.954491,"eighty":-2.820603,"marketCap":15176177},{"date":"2022-12-30","current":-1.532909,"twenty":-5.4859,"median":-3.928883,"eighty":-2.778359,"marketCap":14242259},{"date":"2023-01-06","current":-1.584048,"twenty":-5.469859,"median":-3.892052,"eighty":-2.752363,"marketCap":14717390},{"date":"2023-01-13","current":-1.696252,"twenty":-5.468686,"median":-3.836529,"eighty":-2.70362,"marketCap":15759877},{"date":"2023-01-20","current":-2.257227,"twenty":-5.456819,"median":-3.807103,"eighty":-2.664625,"marketCap":20971894},{"date":"2023-01-27","current":-2.143097,"twenty":-5.410473,"median":-3.730029,"eighty":-2.632,"marketCap":19911517},{"date":"2023-02-03","current":-2.067011,"twenty":-5.399028,"median":-3.715187,"eighty":-2.586636,"marketCap":19204599},{"date":"2023-02-10","current":-2.117735,"twenty":-5.363632,"median":-3.683921,"eighty":-2.56064,"marketCap":19675878},{"date":"2023-02-17","current":-2.472805,"twenty":-5.337817,"median":-3.663107,"eighty":-2.498898,"marketCap":22974827},{"date":"2023-02-24","current":-2.586934,"twenty":-5.307925,"median":-3.659538,"eighty":-2.469653,"marketCap":24035204},{"date":"2023-03-03","current":-2.181267,"twenty":-5.306583,"median":-3.645447,"eighty":-2.421072,"marketCap":20266154},{"date":"2023-03-10","current":-2.168459,"twenty":-5.292609,"median":-3.600668,"eighty":-2.384037,"marketCap":20147156},{"date":"2023-03-17","current":-2.29527,"twenty":-5.24289,"median":-3.553609,"eighty":-2.307663,"marketCap":21325353},{"date":"2023-03-24","current":-1.662583,"twenty":-5.226682,"median":-3.507022,"eighty":-2.269908,"marketCap":20516275},{"date":"2023-03-31","current":-1.643473,"twenty":-5.217,"median":-3.439319,"eighty":-2.231865,"marketCap":20280456},{"date":"2023-04-06","current":-1.624363,"twenty":-5.196838,"median":-3.395772,"eighty":-2.206503,"marketCap":20044637},{"date":"2023-04-14","current":-1.595698,"twenty":-5.188271,"median":-3.35543,"eighty":-2.181242,"marketCap":19690908},{"date":"2023-04-21","current":-1.834574,"twenty":-5.170753,"median":-3.298286,"eighty":-2.165923,"marketCap":22638648},{"date":"2023-04-28","current":-1.815464,"twenty":-5.162095,"median":-3.266725,"eighty":-2.132364,"marketCap":22402829},{"date":"2023-05-05","current":-1.663852,"twenty":-5.104983,"median":-3.246845,"eighty":-2.105764,"marketCap":20531935},{"date":"2023-05-12","current":-1.663852,"twenty":-5.090986,"median":-3.192676,"eighty":-2.067939,"marketCap":20531935},{"date":"2023-05-19","current":-1.635165,"twenty":-5.090986,"median":-3.184406,"eighty":-2.021262,"marketCap":20177936},{"date":"2023-05-26","current":-1.577791,"twenty":-5.070824,"median":-3.160181,"eighty":-1.98273,"marketCap":19469938},{"date":"2023-05-30","current":-1.529979,"twenty":-5.065783,"median":-3.152057,"eighty":-1.972678,"marketCap":18879940},{"date":"2023-06-09","current":-1.667747,"twenty":-5.05857,"median":-3.123684,"eighty":-1.940201,"marketCap":22537929},{"date":"2023-06-16","current":-1.606625,"twenty":-5.04058,"median":-3.08034,"eighty":-1.922419,"marketCap":21711931},{"date":"2023-06-23","current":-1.397065,"twenty":-5.04058,"median":-3.038323,"eighty":-1.882,"marketCap":18879940},{"date":"2023-06-30","current":-1.257359,"twenty":-5.04058,"median":-2.989579,"eighty":-1.815464,"marketCap":16991946},{"date":"2023-07-07","current":-1.340783,"twenty":-5.039584,"median":-2.976275,"eighty":-1.751128,"marketCap":18119348},{"date":"2023-07-14","current":-1.331068,"twenty":-5.029005,"median":-2.934649,"eighty":-1.709433,"marketCap":17988049},{"date":"2023-07-21","current":-1.388002,"twenty":-5.015377,"median":-2.924589,"eighty":-1.68025,"marketCap":18757465},{"date":"2023-07-28","current":-1.32057,"twenty":-5.008078,"median":-2.911088,"eighty":-1.663852,"marketCap":17846185},{"date":"2023-08-04","current":-1.02823,"twenty":-4.994348,"median":-2.893022,"eighty":-1.662583,"marketCap":13895502},{"date":"2023-08-11","current":-1.018149,"twenty":-4.983838,"median":-2.859598,"eighty":-1.65429,"marketCap":13759272},{"date":"2023-08-18","current":-0.785704,"twenty":-4.970589,"median":-2.827102,"eighty":-1.643975,"marketCap":11988276},{"date":"2023-08-25","current":-0.803651,"twenty":-4.964971,"median":-2.794607,"eighty":-1.64232,"marketCap":12262100},{"date":"2023-09-01","current":-0.839275,"twenty":-4.95489,"median":-2.778359,"eighty":-1.635165,"marketCap":12805659},{"date":"2023-09-08","current":-0.832936,"twenty":-4.939768,"median":-2.762111,"eighty":-1.633428,"marketCap":12708935},{"date":"2023-09-15","current":-0.76508,"twenty":-4.939768,"median":-2.737821,"eighty":-1.624363,"marketCap":11673584},{"date":"2023-09-22","current":-0.785526,"twenty":-4.939768,"median":-2.697121,"eighty":-1.608262,"marketCap":11985552},{"date":"2023-09-29","current":-0.669634,"twenty":-4.934856,"median":-2.664625,"eighty":-1.59597,"marketCap":10217281},{"date":"2023-10-06","current":-0.521511,"twenty":-4.911114,"median":-2.63213,"eighty":-1.584467,"marketCap":7957218},{"date":"2023-10-13","current":-0.508922,"twenty":-4.893656,"median":-2.599634,"eighty":-1.571801,"marketCap":7765133},{"date":"2023-10-20","current":-0.482315,"twenty":-4.889362,"median":-2.586934,"eighty":-1.557715,"marketCap":7359167},{"date":"2023-10-27","current":-0.420977,"twenty":-4.889362,"median":-2.583386,"eighty":-1.550731,"marketCap":6423264},{"date":"2023-11-03","current":-0.427673,"twenty":-4.859119,"median":-2.575182,"eighty":-1.529941,"marketCap":6525437},{"date":"2023-11-10","current":-0.473207,"twenty":-4.838957,"median":-2.534643,"eighty":-1.428226,"marketCap":7220198},{"date":"2023-11-17","current":-0.458923,"twenty":-4.823268,"median":-2.50621,"eighty":-1.39344,"marketCap":7002243},{"date":"2023-11-24","current":-0.573296,"twenty":-4.803106,"median":-2.471229,"eighty":-1.365256,"marketCap":8747355},{"date":"2023-12-01","current":-1.530812,"twenty":-4.788551,"median":-2.434888,"eighty":-1.354573,"marketCap":17573724},{"date":"2023-12-08","current":-0.947576,"twenty":-4.768389,"median":-2.421072,"eighty":-1.344766,"marketCap":10878169},{"date":"2023-12-15","current":-1.035548,"twenty":-4.728064,"median":-2.409536,"eighty":-1.33788,"marketCap":11888089},{"date":"2023-12-22","current":-0.924958,"twenty":-4.712942,"median":-2.352334,"eighty":-1.320883,"marketCap":10618514},{"date":"2023-12-29","current":-0.928529,"twenty":-4.712942,"median":-2.34536,"eighty":-1.310489,"marketCap":10659512},{"date":"2024-01-05","current":-0.929719,"twenty":-4.694947,"median":-2.307807,"eighty":-1.276215,"marketCap":10673178},{"date":"2024-01-12","current":-1.105068,"twenty":-4.65558,"median":-2.29527,"eighty":-1.218395,"marketCap":12686186},{"date":"2024-01-19","current":-1.130782,"twenty":-4.627252,"median":-2.269908,"eighty":-1.115354,"marketCap":12981373},{"date":"2024-01-26","current":-1.226134,"twenty":-4.607157,"median":-2.231865,"eighty":-1.134639,"marketCap":14076023},{"date":"2024-02-02","current":-1.541596,"twenty":-4.579679,"median":-2.219184,"eighty":-1.141376,"marketCap":17697524},{"date":"2024-02-09","current":-1.571357,"twenty":-4.548856,"median":-2.206503,"eighty":-1.166661,"marketCap":18039175},{"date":"2024-02-16","current":-1.583261,"twenty":-4.543502,"median":-2.181267,"eighty":-1.20534,"marketCap":18175835},{"date":"2024-02-23","current":-1.499931,"twenty":-4.528904,"median":-2.18114,"eighty":-1.210592,"marketCap":17219212},{"date":"2024-03-01","current":-2.107047,"twenty":-4.48932,"median":-2.162119,"eighty":-1.21423,"marketCap":24188894},{"date":"2024-03-08","current":-2.392748,"twenty":-4.459984,"median":-2.18114,"eighty":-1.214653,"marketCap":27468744},{"date":"2024-03-15","current":-1.654686,"twenty":-4.439699,"median":-2.162119,"eighty":-1.217027,"marketCap":18995798},{"date":"2024-03-22","current":-2.154663,"twenty":-4.408494,"median":-2.143097,"eighty":-1.221037,"marketCap":24735536},{"date":"2024-03-28","current":-2.05943,"twenty":-4.309696,"median":-2.142759,"eighty":-1.226134,"marketCap":23642252},{"date":"2024-04-05","current":-2.452269,"twenty":-4.304438,"median":-2.155221,"eighty":-1.239925,"marketCap":28152046},{"date":"2024-04-12","current":-2.323708,"twenty":-4.284493,"median":-2.154663,"eighty":-1.257359,"marketCap":26211430},{"date":"2024-04-19","current":-2.102403,"twenty":-4.278838,"median":-2.155221,"eighty":-1.270167,"marketCap":23715103},{"date":"2024-04-26","current":-1.936249,"twenty":-4.278838,"median":-2.143097,"eighty":-1.279703,"marketCap":21840892},{"date":"2024-05-03","current":-1.951616,"twenty":-4.234087,"median":-2.139758,"eighty":-1.280247,"marketCap":22014233},{"date":"2024-05-10","current":-1.803785,"twenty":-4.198408,"median":-2.130855,"eighty":-1.285655,"marketCap":20346698},{"date":"2024-05-17","current":-1.874781,"twenty":-4.197795,"median":-2.117455,"eighty":-1.309749,"marketCap":21147531},{"date":"2024-05-24","current":-1.789876,"twenty":-4.197594,"median":-2.10806,"eighty":-1.310489,"marketCap":20189806},{"date":"2024-05-31","current":-1.927374,"twenty":-4.186464,"median":-2.105942,"eighty":-1.311407,"marketCap":19479966},{"date":"2024-06-07","current":-1.963066,"twenty":-4.163519,"median":-2.103728,"eighty":-1.318783,"marketCap":19840706},{"date":"2024-06-14","current":-1.731067,"twenty":-4.157654,"median":-2.092373,"eighty":-1.321196,"marketCap":17495895},{"date":"2024-06-21","current":-1.602576,"twenty":-4.142944,"median":-2.087988,"eighty":-1.321352,"marketCap":16197231},{"date":"2024-06-28","current":-1.604945,"twenty":-4.118154,"median":-2.074553,"eighty":-1.316996,"marketCap":20201446},{"date":"2024-07-05","current":-1.762574,"twenty":-4.104917,"median":-2.071187,"eighty":-1.320883,"marketCap":22185517},{"date":"2024-07-12","current":-1.447317,"twenty":-4.091858,"median":-2.059598,"eighty":-1.321352,"marketCap":18217376},{"date":"2024-07-19","current":-1.048373,"twenty":-4.076953,"median":-2.053627,"eighty":-1.310948,"marketCap":13195873},{"date":"2024-07-26","current":-1.159807,"twenty":-4.038661,"median":-2.035308,"eighty":-1.279921,"marketCap":14598485},{"date":"2024-08-02","current":-1.057831,"twenty":-3.973793,"median":-2.024697,"eighty":-1.246899,"marketCap":13314917},{"date":"2024-08-09","current":-0.944338,"twenty":-3.945355,"median":-2.003606,"eighty":-1.217711,"marketCap":11886386},{"date":"2024-08-16","current":-1.191124,"twenty":-3.930544,"median":-1.990733,"eighty":-1.211681,"marketCap":14992674},{"date":"2024-08-23","current":-1.283939,"twenty":-3.928042,"median":-1.985243,"eighty":-1.211681,"marketCap":16160934},{"date":"2024-08-30","current":-1.376753,"twenty":-3.912889,"median":-1.981631,"eighty":-1.20534,"marketCap":17329195},{"date":"2024-09-06","current":-1.45611,"twenty":-3.887863,"median":-1.96912,"eighty":-1.209999,"marketCap":18328057},{"date":"2024-09-13","current":-2.088334,"twenty":-3.865327,"median":-1.965563,"eighty":-1.211473,"marketCap":26285858},{"date":"2024-09-20","current":-2.010988,"twenty":-3.839942,"median":-1.981631,"eighty":-1.212692,"marketCap":25312307},{"date":"2024-09-27","current":-1.98005,"twenty":-3.830626,"median":-1.98005,"eighty":-1.21423,"marketCap":24922887},{"date":"2024-10-04","current":-2.503926,"twenty":-3.820701,"median":-1.982351,"eighty":-1.214653,"marketCap":24533467},{"date":"2024-10-11","current":-2.245584,"twenty":-3.776823,"median":-1.988004,"eighty":-1.217027,"marketCap":22002236},{"date":"2024-10-18","current":-2.12635,"twenty":-3.743094,"median":-1.988004,"eighty":-1.219877,"marketCap":20833976},{"date":"2024-10-25","current":-2.523798,"twenty":-3.729133,"median":-1.995519,"eighty":-1.221492,"marketCap":24728177},{"date":"2024-11-01","current":-2.648772,"twenty":-3.725547,"median":-2.003739,"eighty":-1.228892,"marketCap":25952672},{"date":"2024-11-08","current":-2.690697,"twenty":-3.721403,"median":-2.016604,"eighty":-1.242231,"marketCap":26363451},{"date":"2024-11-15","current":-2.565548,"twenty":-3.700645,"median":-2.030063,"eighty":-1.251762,"marketCap":25137244},{"date":"2024-11-22","current":-1.902279,"twenty":-3.683921,"median":-2.03445,"eighty":-1.253603,"marketCap":18638532},{"date":"2024-11-29","current":-2.071582,"twenty":-3.683921,"median":-2.025676,"eighty":-1.256014,"marketCap":20297362},{"date":"2024-12-06","current":-2.198189,"twenty":-3.679623,"median":-2.039563,"eighty":-1.257359,"marketCap":21537860},{"date":"2024-12-13","current":-2.029841,"twenty":-3.663107,"median":-2.043819,"eighty":-1.258879,"marketCap":19888385},{"date":"2024-12-20","current":-2.712263,"twenty":-3.663107,"median":-2.059308,"eighty":-1.270167,"marketCap":31451400},{"date":"2024-12-27","current":-2.552718,"twenty":-3.663107,"median":-2.06238,"eighty":-1.277472,"marketCap":29601318},{"date":"2025-01-03","current":-2.37323,"twenty":-3.658824,"median":-2.067591,"eighty":-1.279541,"marketCap":27519975},{"date":"2025-01-10","current":-2.074083,"twenty":-3.655349,"median":-2.072223,"eighty":-1.279921,"marketCap":24051071},{"date":"2025-01-17","current":-2.183472,"twenty":-3.650831,"median":-2.071582,"eighty":-1.281724,"marketCap":25319545},{"date":"2025-01-24","current":-2.203504,"twenty":-3.642201,"median":-2.072865,"eighty":-1.284282,"marketCap":25551835},{"date":"2025-01-31","current":-2.223536,"twenty":-3.62767,"median":-2.074377,"eighty":-1.290474,"marketCap":25784124},{"date":"2025-02-07","current":-2.323695,"twenty":-3.613156,"median":-2.083313,"eighty":-1.309897,"marketCap":26945571},{"date":"2025-02-14","current":-2.313679,"twenty":-3.579646,"median":-2.084805,"eighty":-1.310718,"marketCap":26829426},{"date":"2025-02-21","current":-2.183472,"twenty":-3.578812,"median":-2.088161,"eighty":-1.311636,"marketCap":25319545},{"date":"2025-02-28","current":-2.218528,"twenty":-3.553609,"median":-2.088334,"eighty":-1.32057,"marketCap":25726052},{"date":"2025-03-07","current":-2.2636,"twenty":-3.528406,"median":-2.093757,"eighty":-1.321352,"marketCap":26248703},{"date":"2025-03-14","current":-2.363759,"twenty":-3.520563,"median":-2.103345,"eighty":-1.321352,"marketCap":27410150},{"date":"2025-03-21","current":-2.143409,"twenty":-3.493481,"median":-2.105444,"eighty":-1.324223,"marketCap":24854966},{"date":"2025-03-28","current":-1.99317,"twenty":-3.4664,"median":-2.105834,"eighty":-1.331068,"marketCap":23112796},{"date":"2025-04-04","current":-1.983154,"twenty":-3.439319,"median":-2.103345,"eighty":-1.332821,"marketCap":22996651},{"date":"2025-04-11","current":-2.490498,"twenty":-3.439319,"median":-2.105834,"eighty":-1.335944,"marketCap":25427989},{"date":"2025-04-17","current":-2.427766,"twenty":-3.404481,"median":-2.107047,"eighty":-1.339815,"marketCap":24787491},{"date":"2025-04-25","current":-2.349292,"twenty":-3.369776,"median":-2.116704,"eighty":-1.340783,"marketCap":23986270},{"date":"2025-05-02","current":-2.420013,"twenty":-3.359115,"median":-2.117735,"eighty":-1.340783,"marketCap":24708329},{"date":"2025-05-09","current":-2.452436,"twenty":-3.353842,"median":-2.128602,"eighty":-1.340912,"marketCap":25039372},{"date":"2025-05-16","current":-3.101375,"twenty":-3.335182,"median":-2.136757,"eighty":-1.348588,"marketCap":31665043},{"date":"2025-05-23","current":-3.430309,"twenty":-3.369776,"median":-2.142759,"eighty":-1.350749,"marketCap":35023456},{"date":"2025-05-30","current":-3.52429,"twenty":-3.433913,"median":-2.143253,"eighty":-1.356454,"marketCap":35983003},{"date":"2025-06-06","current":-4.041186,"twenty":-3.504314,"median":-2.143409,"eighty":-1.360215,"marketCap":41260510},{"date":"2025-06-13","current":-5.591874,"twenty":-3.538487,"median":-2.14431,"eighty":-1.361369,"marketCap":57093032},{"date":"2025-06-20","current":-5.756341,"twenty":-3.5758,"median":-2.155221,"eighty":-1.365256,"marketCap":58772239},{"date":"2025-06-27","current":-4.652063,"twenty":-3.626123,"median":-2.155917,"eighty":-1.37266,"marketCap":47497564},{"date":"2025-07-03","current":-4.487596,"twenty":-3.655659,"median":-2.166095,"eighty":-1.377613,"marketCap":45818357},{"date":"2025-07-11","current":-4.957502,"twenty":-3.67632,"median":-2.167308,"eighty":-1.382444,"marketCap":50616091},{"date":"2025-07-18","current":-4.628568,"twenty":-3.710767,"median":-2.173056,"eighty":-1.388401,"marketCap":47257677},{"date":"2025-07-25","current":-4.769539,"twenty":-3.743094,"median":-2.179806,"eighty":-1.391411,"marketCap":48696998},{"date":"2025-08-01","current":-4.229148,"twenty":-3.830626,"median":-2.18114,"eighty":-1.400575,"marketCap":43179604},{"date":"2025-08-08","current":-3.601902,"twenty":-3.829759,"median":-2.182797,"eighty":-1.414616,"marketCap":31185269},{"date":"2025-08-15","current":-3.324649,"twenty":-3.828495,"median":-2.183472,"eighty":-1.417338,"marketCap":28784813},{"date":"2025-08-22","current":-3.239402,"twenty":-3.815734,"median":-2.185967,"eighty":-1.428226,"marketCap":28046741},{"date":"2025-08-29","current":-3.239402,"twenty":-3.776823,"median":-2.193821,"eighty":-1.432044,"marketCap":28046741},{"date":"2025-09-05","current":-3.125739,"twenty":-3.74636,"median":-2.198189,"eighty":-1.447317,"marketCap":27062645},{"date":"2025-09-12","current":-3.267818,"twenty":-3.74636,"median":-2.203504,"eighty":-1.45611,"marketCap":28292765},{"date":"2025-09-19","current":-3.499934,"twenty":-3.730029,"median":-2.203504,"eighty":-1.461647,"marketCap":30302429},{"date":"2025-09-26","current":-3.413159,"twenty":-3.725547,"median":-2.206503,"eighty":-1.469568,"marketCap":29551129},{"date":"2025-10-03","current":-3.557784,"twenty":-3.725547,"median":-2.213056,"eighty":-1.475976,"marketCap":30803295},{"date":"2025-10-10","current":-3.615634,"twenty":-3.71273,"median":-2.22136,"eighty":-1.488027,"marketCap":31304162},{"date":"2025-10-17","current":-3.528859,"twenty":-3.712252,"median":-2.22944,"eighty":-1.488027,"marketCap":30552862},{"date":"2025-10-24","current":-3.355309,"twenty":-3.704826,"median":-2.231865,"eighty":-1.488027,"marketCap":29050262},{"date":"2025-10-31","current":-2.993745,"twenty":-3.683921,"median":-2.233628,"eighty":-1.499931,"marketCap":25919846},{"date":"2025-11-07","current":-2.978993,"twenty":-3.683921,"median":-2.244576,"eighty":-1.499931,"marketCap":25792125},{"date":"2025-11-14","current":-2.653904,"twenty":-3.679623,"median":-2.261599,"eighty":-1.500506,"marketCap":22977505},{"date":"2025-11-21","current":-3.094983,"twenty":-3.673485,"median":-2.2636,"eighty":-1.507779,"marketCap":26796363},{"date":"2025-11-28","current":-3.442084,"twenty":-3.665183,"median":-2.2636,"eighty":-1.511025,"marketCap":29801562},{"date":"2025-12-05","current":-3.471009,"twenty":-3.663107,"median":-2.269908,"eighty":-1.5149,"marketCap":30051996},{"date":"2025-12-12","current":-2.574332,"twenty":-3.663107,"median":-2.279041,"eighty":-1.517364,"marketCap":22288563},{"date":"2025-12-19","current":-2.36665,"twenty":-3.657397,"median":-2.285329,"eighty":-1.52255,"marketCap":20490452},{"date":"2025-12-26","current":-2.364625,"twenty":-3.65504,"median":-2.293458,"eighty":-1.52374,"marketCap":20472922},{"date":"2026-01-02","current":-2.224338,"twenty":-3.650831,"median":-2.285329,"eighty":-1.52374,"marketCap":19258320},{"date":"2026-01-09","current":-3.217598,"twenty":-3.645092,"median":-2.29527,"eighty":-1.525769,"marketCap":27857961},{"date":"2026-01-16","current":-3.397687,"twenty":-3.655349,"median":-2.299508,"eighty":-1.52924,"marketCap":29417175},{"date":"2026-01-23","current":-3.224801,"twenty":-3.652625,"median":-2.303063,"eighty":-1.529902,"marketCap":27920329},{"date":"2026-01-30","current":-3.632927,"twenty":-3.645269,"median":-2.305663,"eighty":-1.530146,"marketCap":31453885},{"date":"2026-02-06","current":-3.327347,"twenty":-3.642233,"median":-2.313679,"eighty":-1.530812,"marketCap":28808169},{"date":"2026-02-13","current":-3.824537,"twenty":-3.655659,"median":-2.318372,"eighty":-1.531231,"marketCap":33112839},{"date":"2026-02-20","current":-3.395977,"twenty":-3.663107,"median":-2.321244,"eighty":-1.532909,"marketCap":29402373},{"date":"2026-02-27","current":-3.478524,"twenty":-3.655969,"median":-2.323708,"eighty":-1.541596,"marketCap":30117061},{"date":"2026-03-06","current":-3.294916,"twenty":-3.65442,"median":-2.343329,"eighty":-1.545474,"marketCap":28527382},{"date":"2026-03-13","current":-3.278715,"twenty":-3.645447,"median":-2.34536,"eighty":-1.545474,"marketCap":28387116},{"date":"2026-03-20","current":-3.042262,"twenty":-3.644559,"median":-2.34941,"eighty":-1.547548,"marketCap":26339904},{"date":"2026-03-27","current":-2.97013,"twenty":-3.632927,"median":-2.354945,"eighty":-1.547626,"marketCap":25715388},{"date":"2026-04-02","current":-2.281476,"twenty":-3.629959,"median":-2.358675,"eighty":-1.552913,"marketCap":25381422},{"date":"2026-04-10","current":-2.319583,"twenty":-3.623028,"median":-2.361217,"eighty":-1.556829,"marketCap":25805363},{"date":"2026-04-17","current":-2.249678,"twenty":-3.618913,"median":-2.349527,"eighty":-1.558428,"marketCap":25027667},{"date":"2026-04-24","current":-2.271603,"twenty":-3.616161,"median":-2.347643,"eighty":-1.562107,"marketCap":25271581},{"date":"2026-05-01","current":-2.608737,"twenty":-3.615634,"median":-2.349527,"eighty":-1.569077,"marketCap":29022196},{"date":"2026-05-08","current":-2.786677,"twenty":-3.615634,"median":-2.361217,"eighty":-1.570604,"marketCap":31001786},{"date":"2026-05-15","current":-2.703744,"twenty":-3.615634,"median":-2.364625,"eighty":-1.571206,"marketCap":30079155},{"date":"2026-05-22","current":-2.456216,"twenty":-3.615634,"median":-2.366966,"eighty":-1.575541,"marketCap":27325405},{"date":"2026-05-29","current":-2.73266,"twenty":-3.607395,"median":-2.367706,"eighty":-1.577309,"marketCap":30400839},{"date":"2026-06-05","current":-2.478777,"twenty":-3.601464,"median":-2.37323,"eighty":-1.581017,"marketCap":27576389},{"date":"2026-06-12","current":-2.348181,"twenty":-3.597278,"median":-2.378341,"eighty":-1.583224,"marketCap":26123511},{"date":"2026-06-18","current":-2.240145,"twenty":-3.591493,"median":-2.370394,"eighty":-1.583576,"marketCap":24921618},{"date":"2026-06-26","current":-2.411731,"twenty":-3.586709,"median":-2.383451,"eighty":-1.584886,"marketCap":26830508},{"date":"2026-07-02","current":-2.297341,"twenty":-3.586709,"median":-2.37323,"eighty":-1.586142,"marketCap":25557914},{"date":"2026-07-10","current":-2.28749,"twenty":-3.586709,"median":-2.367706,"eighty":-1.588053,"marketCap":25448330},{"date":"2026-07-17","current":-2.231566,"twenty":-3.586709,"median":-2.36665,"eighty":-1.595705,"marketCap":24826173},{"date":"2026-07-24","current":-2.08127,"twenty":-3.585446,"median":-2.364192,"eighty":-1.59597,"marketCap":23154127},{"date":"2026-07-31","current":-1.512495,"twenty":-3.580392,"median":-2.361217,"eighty":-1.595698,"marketCap":16826510},{"date":"2026-08-07","current":-1.598288,"twenty":-3.579855,"median":-2.349527,"eighty":-1.586142,"marketCap":17780955},{"date":"2026-08-14","current":-1.472608,"twenty":-3.578812,"median":-2.348737,"eighty":-1.583261,"marketCap":16382765},{"date":"2026-08-21","current":-1.164527,"twenty":-3.572247,"median":-2.34536,"eighty":-1.571357,"marketCap":12955362},{"date":"2026-08-28","current":-1.45865,"twenty":-3.571281,"median":-2.343329,"eighty":-1.558666,"marketCap":16227478}],"updateTime":1788209043597},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NRSN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663005531","title":"NeuroSense announces redesigned development plan for PrimeC","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005531?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:55","pubTimestamp":1788180943,"startTime":"0","endTime":"0","summary":"NeuroSense (NRSN) Therapeutics announced a redesigned development plan for PrimeC in amyotrophic lateral sclerosis, structured to reach a potential...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurosense-announces-redesigned-development-plan-for-primec-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurosense-announces-redesigned-development-plan-for-primec-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663600375","title":"NeuroSense Targets Faster, Lower-Cost ALS Approval Path for PrimeC Under Revamped Development Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2663600375","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663600375?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:45","pubTimestamp":1788180356,"startTime":"0","endTime":"0","summary":"NeuroSense targets faster, lower-cost ALS approval path for PrimeC under revamped development planNeuroSense outlined an accelerated, lower-cost development plan to move PrimeC toward a potential ALS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL4T5KLC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663755003","title":"NeuroSense Plans Head-to-Head PrimeC Trial Versus Mitsubishi Tanabe’s Edaravone in ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2663755003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663755003?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:45","pubTimestamp":1788180331,"startTime":"0","endTime":"0","summary":"NeuroSense plans head-to-head PrimeC trial versus Mitsubishi Tanabe’s edaravone in ALSNeuroSense outlined a redesigned development plan for PrimeC in ALS, aiming to speed a regulatory filing while cut","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL8CzGkh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663003735","title":"Neurosense Unveils Accelerated, Capital-Efficient Strategy to Advance Primec Toward Potential Approval in ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2663003735","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663003735?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:45","pubTimestamp":1788180300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA1WYPLN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662384420","title":"NeuroSense Therapeutics Shareholders Authorized Board to Pursue Reverse Stock Split Range 1-for-4 to 1-for-40","url":"https://stock-news.laohu8.com/highlight/detail?id=2662384420","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662384420?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:16","pubTimestamp":1787861775,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics shareholders authorized board to pursue reverse stock split range 1-for-4 to 1-for-40NeuroSense Therapeutics held a special shareholder meeting on Aug. 26, 2026.Shareholders au","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL2ns8Y1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659506111","title":"NeuroSense Announces Shareholder Letter Availability","url":"https://stock-news.laohu8.com/highlight/detail?id=2659506111","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659506111?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:36","pubTimestamp":1786628198,"startTime":"0","endTime":"0","summary":"NeuroSense announces shareholder letter availabilityNeuroSense Therapeutics released a CEO letter to shareholders outlining near-term priorities for PrimeC in ALS.FDA clearance received to start the P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1jwkbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659505181","title":"NeuroSense Targets December 2026 Canada Filing for PrimeC ALS Drug Amid Phase 3 Paragon Preparations","url":"https://stock-news.laohu8.com/highlight/detail?id=2659505181","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659505181?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:31","pubTimestamp":1786627898,"startTime":"0","endTime":"0","summary":"NeuroSense targets December 2026 Canada filing for PrimeC ALS drug amid Phase 3 PARAGON preparationsNeuroSense set plans to launch the Phase 3 PARAGON trial of PrimeC in ALS, targeting about 300 parti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL5gxNSB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911286","title":"Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911286?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:40","pubTimestamp":1786462847,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurosense Therapeutics Ltd. (NRSN) and Brookdale Se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurosense-therapeutics-ltd-nrsn-and-brookdale-senior-living-bkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurosense-therapeutics-ltd-nrsn-and-brookdale-senior-living-bkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","XBI","LABU","NRSN","LU2190626999.HKD","LU1499592464.USD","BK4137","HCSG","BK4581","LU0128526141.USD","XLV","LU0029874061.USD","BKD","LU0842063009.USD","BK4185","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657865378","title":"NeuroSense sees December 2026 as filing date for NDS for PrimeC","url":"https://stock-news.laohu8.com/highlight/detail?id=2657865378","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657865378?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:35","pubTimestamp":1786030550,"startTime":"0","endTime":"0","summary":"NeuroSense (NRSN) Therapeutics announced that it is targeting December 2026 for the filing of a New Drug Submission with Health Canada for PrimeC, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurosense-sees-december-2026-as-filing-date-for-nds-for-primec-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurosense-sees-december-2026-as-filing-date-for-nds-for-primec-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656991253","title":"NeuroSense Therapeutics Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2656991253","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656991253?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:17","pubTimestamp":1785529029,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics announces special shareholder meetingNeuroSense Therapeutics will hold a special shareholder meeting in Ra’anana, Israel on Aug. 26, 2026.Shareholders will vote on authorizing ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL7D2jht:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656399194","title":"NeuroSense Amends JonesTrading Equity Distribution Agreement for up to $3.79 Million Share Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2656399194","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656399194?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:16","pubTimestamp":1785529007,"startTime":"0","endTime":"0","summary":"NeuroSense amends JonesTrading equity distribution agreement for up to $3.79 million share salesNeuroSense amended its JonesTrading Capital on Demand sales agreement to align it with a new Form F-3 re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL4jWWF9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654192006","title":"Neurosense Therapeutics Ltd Expected to Post Breakeven Results a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2654192006","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654192006?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:03","pubTimestamp":1785236585,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd <NRSN.OQ> expected to post breakeven results a share - Earnings PreviewNeurosense Therapeutics LtdNRSN.OQNRSN.Ois expected to  report resultson July 30  for the period ending March 31 2026LSEG's mean analyst estimate for Neurosense Therapeutics Ltd is for breakeven results per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 3 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Neurosense Therapeutics Ltd is $7.50, about 1,177.7% above its last closing price of $0.59This summary was machine generated July 28 at 11:03 GMT.  All figures in US dollars unless otherwise stated.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL8N43U184:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653750737","title":"Neurosense Therapeutics - Expects to File Submission to Health Canada in Coming Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2653750737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653750737?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:35","pubTimestamp":1784723718,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653750401","title":"Neurosense Therapeutics Announces Press Release Availability","url":"https://stock-news.laohu8.com/highlight/detail?id=2653750401","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653750401?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:31","pubTimestamp":1784723495,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics announces press release availabilityNeuroSense flagged plans to file a New Drug Submission with Health Canada for PrimeC in ALS in coming months.Regulatory path follows a pre-s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL4vvLPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653504027","title":"Neurosense Plans Primec New Drug Filing with Health Canada for ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2653504027","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653504027?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:31","pubTimestamp":1784723463,"startTime":"0","endTime":"0","summary":"NeuroSense plans PrimeC new drug filing with Health Canada for ALSNeuroSense plans to file a New Drug Submission with Health Canada for PrimeC to treat ALS following a Pre-NDS meeting.The submission p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL3zKdw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648668810","title":"Neurosense Therapeutics Ltd. (NRSN) Gets a Buy from Noble Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2648668810","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648668810?lang=en_us&edition=fundamental","pubTime":"2026-07-02 21:05","pubTimestamp":1782997516,"startTime":"0","endTime":"0","summary":"Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Neurosense Therapeutics Ltd. today and set a price target of $9.00. LeBoyer cover...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/neurosense-therapeutics-ltd-nrsn-gets-a-buy-from-noble-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/neurosense-therapeutics-ltd-nrsn-gets-a-buy-from-noble-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBL","NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647110370","title":"Neurosense Therapeutics Achieves Primary Endpoint in Phase 2B ALS Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2647110370","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647110370?lang=en_us&edition=fundamental","pubTime":"2026-06-29 22:34","pubTimestamp":1782743682,"startTime":"0","endTime":"0","summary":"BRIEF-Neurosense Therapeutics Achieves Primary Endpoint In Phase 2B ALS StudyJune 29 (Reuters)-Neurosense Therapeutics LtdNRSN.O:NEUROSENSE ACHIEVES PRIMARY ENDPOINT IN PHASE 2B ALS STUDY WITH STATIST","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA3QGJ3T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSNW","NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647377807","title":"Neurosense Rises as Nerve Disease Drug Shows Promise in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2647377807","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647377807?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:51","pubTimestamp":1782741084,"startTime":"0","endTime":"0","summary":"BUZZ-NeuroSense rises as nerve disease drug shows promise in study** U.S.-listed shares of Israel-based drug developer NeuroSense TherapeuticsNRSN.Orise 6.3% to 80 cents** NRSN says its experimental o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nL4N43114F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647372744","title":"NeuroSense says Phase 2b PARADIGM study of PrimeC in ALS met endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2647372744","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647372744?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:35","pubTimestamp":1782740117,"startTime":"0","endTime":"0","summary":"NeuroSense (NRSN) Therapeutics announced that its Phase 2b PARADIGM study of PrimeC in amyotrophic lateral sclerosis has successfully met its prima...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurosense-says-phase-2b-paradigm-study-of-primec-in-als-met-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurosense-says-phase-2b-paradigm-study-of-primec-in-als-met-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647372942","title":"Neurosense Says Phase 2b ALS Trial Meets Primary Endpoint, Cuts Tdp-43 vs Placebo (p=0.0421)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647372942","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647372942?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:30","pubTimestamp":1782739841,"startTime":"0","endTime":"0","summary":"NeuroSense says Phase 2b ALS trial meets primary endpoint, cuts TDP-43 vs placebo (p=0.0421)NeuroSense reported Phase 2b PARADIGM results showing its PrimeC ALS candidate met the trial’s primary endpo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL7J57lw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":61,"code":"91000000","status":"200"}]}}